METHOD FOR TREATING THE CASES OF POSTOPERATIVE INFLAMMATORY COMPLICATIONS AFTER CATARACT EXTRACTION AND ARTIFICIAL EYE LENS IMPLANTATION

FIELD: medicine. ^ SUBSTANCE: method involves applying IAG-laser treatment to exudates fixation region. Then, drug mixture is additionally introduced into lymphatic orbit region. The mixture has Lidocaine 20-40 mg, Dalargin 1-2 mg, Mexidol 50-100 mg, Lidase 16-32 units, Hemase 3000-5000 IU. The drug...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CHERNYKH VALERIJ VJACHESLAVOVICH, BRATKO VLADIMIR IVANOVICH, LYSIKOV ANDREJ GENNAD'EVICH
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	BANDAGES, DRESSINGS OR ABSORBENT PADS DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS ELECTROTHERAPY FILTERS IMPLANTABLE INTO BLOOD VESSELS FIRST-AID KITS FOMENTATION HUMAN NECESSITIES HYGIENE MAGNETOTHERAPY MEDICAL OR VETERINARY SCIENCE ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROSTHESES RADIATION THERAPY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TREATMENT OR PROTECTION OF EYES OR EARS ULTRASOUND THERAPY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine. ^ SUBSTANCE: method involves applying IAG-laser treatment to exudates fixation region. Then, drug mixture is additionally introduced into lymphatic orbit region. The mixture has Lidocaine 20-40 mg, Dalargin 1-2 mg, Mexidol 50-100 mg, Lidase 16-32 units, Hemase 3000-5000 IU. The drug mixture is introduced into the lymphatic orbit region daily by carrying out pterygopalatine block on the same side with the injured eye with 3-5 blocks in a course. ^ EFFECT: accelerated postoperative rehabilitation; accelerated exudates destruction; arrested inflammatory process with drug mixture. ^ 3 cl